Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Midgut Neuroendocrine Tumors × Endocrine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1 Endocrine 1

Conditions

Neuroendocrine Tumors 378 Pituitary Neoplasms 154 Multiple Endocrine Neoplasia Type 1 150 Thyroid Cancer, Papillary 120 Pheochromocytoma 106 Carcinoma, Neuroendocrine 92 Thyroid Neoplasms 74 Paraganglioma 67 Carcinoid Tumor 66 Neoplasms 54 Thyroid Carcinoma, Anaplastic 50 Adrenocortical Carcinoma 47 Adrenal Gland Neoplasms 46 Neoplasm Metastasis 40 Insulinoma 38 Pancreatic Neoplasms 36 Gastro-enteropancreatic neuroendocrine tumor 36 Adenoma, Islet Cell 36 Carcinoma, Medullary 28 Neuroblastoma 27 Adenocarcinoma, Follicular 27 Hyperaldosteronism 25 Prostatic Neoplasms 24 Obesity 23 Lung Neoplasms 23 Pituitary Diseases 21 Brain Neoplasms 21 Differentiated Thyroid Cancer 20 Cushing Syndrome 20 Sarcoma 19

Interventions

Blood Specimen Collection 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03667092 2025-04-10

GENEBIOLuNET

University Hospital, Toulouse

Phase NA Completed

Midgut Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡